Project Details
| Status | Active |
|---|---|
| Effective start/end date | 2/07/24 → 1/07/29 |
Clinical Trial Phase
- Phase I
- Phase II
A Phase I/IIa Multi-center, Open-label Master Protocol to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of AZD8205 in Participants with Advanced or Metastatic Solid Malignancies
- Frentzas, Sophia (Primary Chief Investigator (PCI))
Project: Research